Alexandria Real Estate Equities, Inc. $ARE Shares Acquired by Corient Private Wealth LLC

Corient Private Wealth LLC increased its stake in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE) by 52.9% in the fourth quarter, HoldingsChannel reports. The firm owned 36,557 shares of the real estate investment trust’s stock after buying an additional 12,649 shares during the quarter. Corient Private Wealth LLC’s holdings in Alexandria Real Estate Equities were worth $1,790,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in ARE. Flax Pond Capital LLC acquired a new stake in shares of Alexandria Real Estate Equities during the fourth quarter worth $2,809,000. Hsbc Holdings PLC increased its stake in Alexandria Real Estate Equities by 92.9% in the fourth quarter. Hsbc Holdings PLC now owns 1,056,161 shares of the real estate investment trust’s stock valued at $51,666,000 after purchasing an additional 508,578 shares during the last quarter. Alpine Global Management LLC purchased a new position in Alexandria Real Estate Equities during the fourth quarter worth about $201,000. MidFirst Bank purchased a new position in Alexandria Real Estate Equities during the fourth quarter worth about $156,000. Finally, Kera Capital Partners Inc. lifted its position in Alexandria Real Estate Equities by 19.0% during the fourth quarter. Kera Capital Partners Inc. now owns 7,753 shares of the real estate investment trust’s stock worth $379,000 after buying an additional 1,240 shares during the period. Institutional investors and hedge funds own 96.54% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on ARE shares. Citigroup restated an “outperform” rating on shares of Alexandria Real Estate Equities in a report on Monday, May 4th. Jefferies Financial Group decreased their price target on shares of Alexandria Real Estate Equities from $57.00 to $47.00 and set a “hold” rating on the stock in a report on Tuesday, April 14th. The Goldman Sachs Group restated a “neutral” rating and set a $52.00 price objective on shares of Alexandria Real Estate Equities in a report on Tuesday, May 19th. Evercore increased their target price on Alexandria Real Estate Equities from $55.00 to $58.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, JPMorgan Chase & Co. reduced their target price on Alexandria Real Estate Equities from $63.00 to $57.00 and set a “neutral” rating on the stock in a report on Tuesday, March 10th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $51.62.

Insider Buying and Selling

In related news, EVP Gregory Calvin Thomas bought 3,500 shares of the stock in a transaction dated Thursday, April 30th. The stock was acquired at an average price of $41.00 per share, for a total transaction of $143,500.00. Following the completion of the purchase, the executive vice president owned 33,024 shares in the company, valued at $1,353,984. This represents a 11.85% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Marc E. Binda sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $54.00, for a total value of $108,000.00. Following the sale, the chief financial officer owned 188,264 shares in the company, valued at approximately $10,166,256. The trade was a 1.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.35% of the stock is owned by company insiders.

Alexandria Real Estate Equities Price Performance

ARE opened at $55.57 on Tuesday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.65. Alexandria Real Estate Equities, Inc. has a 52-week low of $39.41 and a 52-week high of $88.24. The company has a 50 day moving average of $48.82 and a two-hundred day moving average of $50.13. The company has a market cap of $9.68 billion, a P/E ratio of -8.86, a P/E/G ratio of 6.69 and a beta of 1.19.

Alexandria Real Estate Equities (NYSE:ARE) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $1.73 EPS for the quarter, meeting analysts’ consensus estimates of $1.73. The business had revenue of $671.02 million for the quarter, compared to the consensus estimate of $684.78 million. Alexandria Real Estate Equities had a negative net margin of 36.03% and a negative return on equity of 5.21%. The business’s revenue for the quarter was down 11.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.30 EPS. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.300-6.500 EPS. On average, analysts expect that Alexandria Real Estate Equities, Inc. will post 6.4 earnings per share for the current year.

Alexandria Real Estate Equities Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th will be given a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.88 annualized dividend and a yield of 5.2%. Alexandria Real Estate Equities’s dividend payout ratio (DPR) is -45.93%.

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.